» Articles » PMID: 32904593

A Single Large Dose of Vitamin D Could Be Used As a Means of Coronavirus Disease 2019 Prevention and Treatment

Overview
Specialty Pharmacology
Date 2020 Sep 9
PMID 32904593
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

There is no specific and effective medication for coronavirus disease 2019 (COVID-19), and avaccine is not available in recent months. Here, we hypothesize that a single large dose of vitamin D (Vit D) could be an option for trial in COVID-19. Vit D deficiency or insufficiency is very common in the general population as well as in patients with COVID-19. It has been shown that low Vit D level is associated with viral infection, and Vit D supplementation is beneficial for people infected with viruses, such as HIV and hepatitis C virus. Although COVID-19 is a respiratory disease, the morbidity and mortality of this disease are driven by coagulopathy. Clinical studies have shown that Vit D can exert anticoagulant effects. Vit D, a lipid-soluble vitamin, can be administered as a draught. Vit D supplementation is safe and has rare toxic events. In addition, the cost of Vit D is fairly low. Based on these observations, we speculate that a single dose of 300,000 IU Vit D may have a role in the prevention and treatment of COVID-19.

Citing Articles

Physiological Basis for Using Vitamin D to Improve Health.

Wimalawansa S Biomedicines. 2023; 11(6).

PMID: 37371637 PMC: 10295227. DOI: 10.3390/biomedicines11061542.


Vitamin D-A prominent immunomodulator to prevent COVID-19 infection.

Ashique S, Gupta K, Gupta G, Mishra N, Singh S, Wadhwa S Int J Rheum Dis. 2022; 26(1):13-30.

PMID: 36308699 PMC: 9874620. DOI: 10.1111/1756-185X.14477.


Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality.

Kodidela S, Godse S, Kumar A, Nguyen X, Cernasev A, Zhou L Biology (Basel). 2022; 11(2).

PMID: 35205044 PMC: 8869385. DOI: 10.3390/biology11020177.


Vitamin D and COVID-19: where are we now?.

Contreras-Bolivar V, Garcia-Fontana B, Garcia-Fontana C, Munoz-Torres M Postgrad Med. 2021; 135(3):195-207.

PMID: 34886758 PMC: 8787834. DOI: 10.1080/00325481.2021.2017647.


Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease.

Lakkireddy M, Gadiga S, Malathi R, Karra M, Raju I, Ragini Sci Rep. 2021; 11(1):10641.

PMID: 34017029 PMC: 8138022. DOI: 10.1038/s41598-021-90189-4.


References
1.
Hejazi M, Modarresi-Ghazani F, Hamishehkar H, Mesgari-Abbasi M, Dousti S, Entezari-Maleki T . The Effect of Treatment of Vitamin D Deficiency on the Level of P-Selectin and hs-CRP in Patients With Thromboembolism: A Pilot Randomized Clinical Trial. J Clin Pharmacol. 2016; 57(1):40-47. DOI: 10.1002/jcph.774. View

2.
Bergqvist C, Ezzedine K . Vitamin D and the skin: what should a dermatologist know?. G Ital Dermatol Venereol. 2019; 154(6):669-680. DOI: 10.23736/S0392-0488.19.06433-2. View

3.
Ren B, Yan F, Deng Z, Zhang S, Xiao L, Wu M . Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan. Circulation. 2020; 142(2):181-183. DOI: 10.1161/CIRCULATIONAHA.120.047407. View

4.
Tang N, Li D, Wang X, Sun Z . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4):844-847. PMC: 7166509. DOI: 10.1111/jth.14768. View

5.
Murdaca G, Tonacci A, Negrini S, Greco M, Borro M, Puppo F . Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications. Autoimmun Rev. 2019; 18(9):102350. DOI: 10.1016/j.autrev.2019.102350. View